4 Form 4 filings for NKTR between 2026-07-24 and 2026-08-20, from 2 filers. 4 discretionary (2 sales, 0 purchases). None state a filing-level total — that aggregate began on 2026-08-17 — so each row below shows only its largest transaction. Prices ran $72 to $72.
| Filed | Filer | Role | Action | Shares largest txn | Price | Filing total | Txns |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Zalevsky Jonathan | sold | 186 | $71.98 | — | — | |
| 2026-08-20 | ROBIN HOWARD W | sold | 418 | $71.98 | — | — | |
| 2026-07-24 | Zalevsky Jonathan (Chief R&D Officer at NEKTAR THERAPEUTICS) filed a Form 4; no parseable transaction details were found in the filing. | ||||||
| 2026-07-24 | ROBIN HOWARD W (President & CEO at NEKTAR THERAPEUTICS) filed a Form 4; no parseable transaction details were found in the filing. | ||||||
| 4 filings · 2 filers · disclosed totals only | $0 (0/4) | — | |||||